| Primary |
| Acarodermatitis |
34.6% |
| Onchocerciasis |
25.7% |
| Hypertension |
5.1% |
| Pruritus |
4.7% |
| Filariasis Lymphatic |
3.6% |
| Constipation |
3.4% |
| Strongyloidiasis |
3.2% |
| Depression |
2.1% |
| Parkinson's Disease |
1.8% |
| Epilepsy |
1.7% |
| Hyperlipidaemia |
1.7% |
| Gastritis |
1.6% |
| Diabetes Mellitus |
1.5% |
| Prophylaxis |
1.5% |
| Insomnia |
1.4% |
| Hepatic Encephalopathy |
1.3% |
| Arrhythmia |
1.3% |
| Cerebral Infarction |
1.3% |
| Dementia |
1.3% |
| Gastroenteritis |
1.3% |
|
| Pyrexia |
21.4% |
| Vertigo |
18.6% |
| Urinary Incontinence |
11.0% |
| Ocular Hyperaemia |
9.6% |
| Vomiting |
8.9% |
| Pruritus |
4.9% |
| Headache |
2.7% |
| Coma |
2.4% |
| Toxic Epidermal Necrolysis |
2.3% |
| Speech Disorder |
2.2% |
| Platelet Count Decreased |
2.1% |
| Pain |
2.0% |
| Stupor |
2.0% |
| Liver Disorder |
1.7% |
| Gait Disturbance |
1.5% |
| Somnolence |
1.5% |
| Conjunctival Haemorrhage |
1.3% |
| Depressed Level Of Consciousness |
1.3% |
| No Adverse Event |
1.3% |
| Swelling Face |
1.3% |
|
| Secondary |
| Acarodermatitis |
42.3% |
| Hypertension |
5.7% |
| Onchocerciasis |
5.4% |
| Pruritus |
5.4% |
| Constipation |
5.2% |
| Strongyloidiasis |
4.6% |
| Filariasis Lymphatic |
4.5% |
| Product Used For Unknown Indication |
3.7% |
| Hyperlipidaemia |
3.2% |
| Gastritis |
2.5% |
| Prophylaxis |
2.5% |
| Pneumonia |
2.4% |
| Cholecystitis |
1.7% |
| Depression |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Arrhythmia |
1.6% |
| Insomnia |
1.6% |
| Parkinson's Disease |
1.6% |
| Acrodermatitis |
1.3% |
| Cerebral Infarction |
1.3% |
|
| Prescribed Overdose |
15.0% |
| Platelet Count Decreased |
10.2% |
| Inappropriate Schedule Of Drug Administration |
7.5% |
| Toxic Epidermal Necrolysis |
7.5% |
| Septic Shock |
6.8% |
| Marasmus |
5.4% |
| Pyrexia |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Decreased Appetite |
4.1% |
| Incorrect Route Of Drug Administration |
4.1% |
| Strongyloidiasis |
4.1% |
| Cardiac Failure |
3.4% |
| Scrotal Oedema |
3.4% |
| Aplastic Anaemia |
2.7% |
| Conjunctival Haemorrhage |
2.7% |
| Pneumothorax |
2.7% |
| Purpura |
2.7% |
| Renal Failure Acute |
2.7% |
| Vertigo |
2.7% |
| Vomiting |
2.7% |
|
| Concomitant |
| Schizophrenia, Paranoid Type |
15.9% |
| Rheumatoid Arthritis |
13.6% |
| Pharyngitis |
9.1% |
| Product Used For Unknown Indication |
9.1% |
| Asthma |
6.8% |
| Acarodermatitis |
4.5% |
| Influenza |
4.5% |
| Insomnia |
4.5% |
| Pneumonia |
4.5% |
| Drug Use For Unknown Indication |
3.4% |
| Hiv Infection |
3.4% |
| Abdominal Pain Upper |
2.3% |
| Bronchitis |
2.3% |
| Constipation |
2.3% |
| Cough |
2.3% |
| Dysmenorrhoea |
2.3% |
| Flatulence |
2.3% |
| Gastrointestinal Disorder |
2.3% |
| Parkinsonism |
2.3% |
| Scleroderma |
2.3% |
|
| Myalgia |
9.1% |
| Strongyloidiasis |
9.1% |
| Weight Increased |
9.1% |
| Asthenia |
4.5% |
| Autoimmune Hepatitis |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Lichenoid Keratosis |
4.5% |
| Ocular Icterus |
4.5% |
| Pneumonia |
4.5% |
| Pneumonia Pneumococcal |
4.5% |
| Psoriasis |
4.5% |
| Pulmonary Embolism |
4.5% |
| Renal Failure |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Tuberculosis |
4.5% |
| Tumour Haemorrhage |
4.5% |
| Type 2 Diabetes Mellitus |
4.5% |
| Weight Decreased |
4.5% |
| Wrong Technique In Drug Usage Process |
4.5% |
|
